⚠️FDA requests market withdrawal of all remaining prescription and OTC ranitidine (Zantac) products on the U.S. market. This means that ranitidine will not be available for use in the U.S. https://t.co/kfcW0wlHo6 pic.twitter.com/IvrLcmrMn5
— FDA Drug Information (@FDA_Drug_Info) April 1, 2020